Âé¶ą´«Ă˝É«ÇéƬ

Health Observance

Debunking common myths about arthritis

May is Arthritis Awareness Month
Racheal D'Souza
May 3, 2022

Arthritis causes pain, swelling and inflammation of one or multiple joints. It’s not a single disease but an umbrella term used to refer to a wide array of conditions. It’s one of the most widespread health conditions in the nation.

There are , of which is the most common. Osteoarthritis, also known as degenerative joint disease, occurs over time due to wear and tear of cartilage that protects the ends of the bones. Although osteoarthritis can damage any joint, the disorder most commonly affects joints in the hands, knees, hips and spine.

There are also , such as rheumatoid arthritis; psoriatic arthritis; and the arthritis associated with ankylosing spondylitis, lupus and gout. In those cases, inflammation is caused by an overactive immune system that attacks connective tissues. (Learn more about autoinflammatory arthritis.)

In the United States, an estimated are gripped with arthritis — the leading cause of disability. More than 50% of this population fall in the working age group (18 to 64 years).

Despite how common this condition is, there are several myths that persist, making it confusing for patients seeking to relieve their symptoms and to improve their quality of life. This article aims at debunking these long-held myths and getting your facts straight!

Myth #1: Arthritis is an old-age disease and cannot affect children.

Fact: Arthritis is more common in older adults, but there are several types that can affect both children and young adults.

Juvenile idiopathic arthritis (also known as childhood arthritis or juvenile rheumatoid arthritis) is the most common type of arthritis among children and can cause permanent physical damage to joints. According to , one in 1,000 children (or about 300,000 children in the U.S.) are affected.

Myth #2: All joint pain is arthritis.

Fact: There are many conditions — such as ,  and other soft-tissue injuries — that cause joint pain and have a pain profile similar to that of arthritis. Hence, it is of utmost importance to get an accurate medical diagnosis, preferably by a rheumatologist, before treating any kind of joint pain.

Myth #3: When you start experiencing joint pain, you should wait to see if it goes away on its own.

Fact: False! Diagnosing and treating arthritis at its early stage not only can save your joints but also save you from damage to vital organs. Certain forms, such as rheumatoid arthritis, can damage skin, eyes, lungs, blood vessels, the brain and the heart. It is important to determine which type of arthritis you have right away, because treatment varies and starting the correct treatment can be the key to preventing permanent damage.

Myth #4: Arthritis symptoms cannot be improved.

Fact: There currently isn’t a cure for arthritis. However, treatment focuses on relieving symptoms and improving joint function. Working with an arthritis expert can help.

Depending upon the type of arthritis, certain medications can reduce pain and inflammation. Osteoarthritis often is treated with pain-reducing medications, physical activity, weight loss (if the person is overweight) and self-management education.(.) Inflammatory disorders are treated with that suppress the immune system.

Heat and cold treatment and assistive devices, such as walkers, braces and gloves, also can help.

Myth #5: Exercising will worsen your condition.

Fact: Exercise can help increase strength, motion and flexibility and reduce pain and swelling. Inactivity can cause the symptoms to worsen, thus increasing both pain and swelling. Before you enroll in any exercise program, it is also important to know what your limits are and what level of exercise you can benefit from.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Racheal D'Souza

Racheal D’Souza is an associate scientist working on CRISPR, with a strong interest in writing. 
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.